Synergism and Rules from Combination of Baicalin, Jasminoidin and Desoxycholic acid in Refined Qing Kai Ling for Treat Ischemic Stroke Mice Model

Refined Qing-Kai-Ling (QKL), a modified Chinese medicine, consists of three main ingredients (Baicalin, Jasminoidin and Desoxycholic acid), plays a synergistic effect on the treatment of the acute stage of ischemic stroke. However, the rules of the combination and synergism are still unknown. Based on the ischemic stroke mice model, all different kinds of combination of Baicalin, Jasminoidin, and Desoxycholic acid were investigated by the methods of neurological examination, microarray, and genomics analysis. As a result, it confirmed that the combination of three drugs offered a better therapeutical effect on ischemic stroke than monotherapy of each drug. Additionally, we used Ingenuity pathway Analysis (IPA) and principal component analysis (PCA) to extract the dominant information of expression changes in 373 ischemia-related genes. The results suggested that 5 principal components (PC1-5) could account for more than 95% energy in the gene data. Moreover, 3 clusters (PC1, PC2+PC5, and PC3+PC4) were addressed with cluster analysis. Furthermore, we matched PCs on the drug-target networks, the findings demonstrated that Baicalin related with PC1 that played the leading role in the combination; Jasminoidin related with PC2+PC5 that played a compensatory role; while Desoxycholic acid had the least performance alone which could relate with PC3+PC4 that played a compatible role. These manifestations were accorded with the principle of herbal formulae of Traditional Chinese Medicine (TCM), emperor-minister-adjuvant-courier. In conclusion, we firstly provided scientific evidence to the classic theory of TCM formulae, an initiating holistic viewpoint of combination therapy of TCM. This study also illustrated that PCA might be an applicable method to analyze the complicated data of drug combination.

[1]  J. Donovan,et al.  A Polypill for All? Critical Review of the Polypill Literature for Primary Prevention of Cardiovascular Disease and Stroke , 2012, The Annals of pharmacotherapy.

[2]  R. Neubig,et al.  Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[3]  Zhan-jun Zhang,et al.  A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia–reperfusion injury , 2006, Brain Research.

[4]  Danh V. Nguyen,et al.  Tumor classification by partial least squares using microarray gene expression data , 2002, Bioinform..

[5]  Dan Liu,et al.  Refined Qingkailing Protects MCAO Mice from Endoplasmic Reticulum Stress-Induced Apoptosis with a Broad Time Window , 2012, Evidence-based complementary and alternative medicine : eCAM.

[6]  S. Koizumi,et al.  Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase , 2007, Neuroscience.

[7]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[8]  E. Birney,et al.  Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs , 2002, Nature.

[9]  V. B. Konkimalla,et al.  Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. , 2007, Current medicinal chemistry.

[10]  Hua Li,et al.  Determination of amino acid neurotransmitters in cerebral cortex of rats administered with baicalin prior to cerebral ischemia by capillary electrophoresis-laser-induced fluorescence detection. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[12]  Ken-ichi Yoshida,et al.  Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS Pathways , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Yongyan Wang,et al.  Gene expression profile induced by oral administration of baicalin and gardenin after focal brain ischemia in rats , 2005, Acta Pharmacologica Sinica.

[14]  Yong Liu,et al.  Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice , 2009, Neuroscience Letters.

[15]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[16]  A. Marini,et al.  Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotype. , 2004, Restorative neurology and neuroscience.

[17]  Xiao Han,et al.  Reduced neuronal nitric oxide synthase is involved in ischemia‐induced hippocampal neurogenesis by up‐regulating inducible nitric oxide synthase expression , 2007, Journal of neurochemistry.

[18]  P. Carmeliet,et al.  Smad3-Dependent Induction of Plasminogen Activator Inhibitor-1 in Astrocytes Mediates Neuroprotective Activity of Transforming Growth Factor-β1 against NMDA-Induced Necrosis , 2002, Molecular and Cellular Neuroscience.

[19]  Andrea Caricasole,et al.  Induction of the Wnt Antagonist, Dickkopf-1, Contributes to the Development of Neuronal Death in Models of Brain Focal Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Robert V Farese,et al.  Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Fisher.  Advances in Stroke 2007: introduction. , 2008, Stroke.

[22]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[23]  F. Barone,et al.  Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study , 1993, Brain Research Bulletin.

[24]  D. Maysinger,et al.  Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion , 1996, Acta Neuropathologica.

[25]  Shiro Watanabe,et al.  Roles of bile acid conjugates and phospholipids in in vitro activation of pancreatic lipase by bear bile and cattle bile. , 2009, Journal of ethnopharmacology.

[26]  W. Kernan,et al.  What Is the Future of Stroke Prevention?: Debate: Polypill Versus Personalized Risk Factor Modification , 2010, Stroke.

[27]  S. Rogers,et al.  Inflammatory Cytokines IL-1α, IL-1β, IL-6, and TNF-α Impart Neuroprotection to an Excitotoxin Through Distinct Pathways , 1999, The Journal of Immunology.

[28]  S. Borkan,et al.  Hsp72 Interacts with Paxillin and Facilitates the Reassembly of Focal Adhesions during Recovery from ATP Depletion* , 2004, Journal of Biological Chemistry.

[29]  S. Rogers,et al.  Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. , 1999, Journal of immunology.

[30]  S. Bates,et al.  Stroke Genomics: Approaches to Identify, Validate, and Understand Ischemic Stroke Gene Expression , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  S. Shen,et al.  Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. , 2006, Toxicology and applied pharmacology.

[32]  The FANTOM Consortium and the RIKEN Genome Exploration Team,et al.  Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs , 2002 .

[33]  Bo Wu,et al.  Meta-Analysis of Traditional Chinese Patent Medicine for Ischemic Stroke , 2007, Stroke.

[34]  P. Pelicci,et al.  The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. , 2009, Biochimica et biophysica acta.

[35]  J. O'Brien,et al.  Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways , 2009, Stroke.

[36]  Peng-tao Li,et al.  Refined Qing Kai Ling, traditional Chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase. , 2008, Biological & pharmaceutical bulletin.

[37]  R. A. van den Berg,et al.  Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.

[38]  J. Roder,et al.  Mechanisms Underlying the Neuronal Calcium Sensor-1-evoked Enhancement of Exocytosis in PC12 Cells* , 2002, The Journal of Biological Chemistry.

[39]  J. van der Greef,et al.  The role of analytical sciences in medical systems biology. , 2004, Current opinion in chemical biology.

[40]  Y. A. Minamishima,et al.  ASC is a Bax adaptor and regulates the p53–Bax mitochondrial apoptosis pathway , 2004, Nature Cell Biology.

[41]  J. Svaren,et al.  Transcription factor early growth response‐1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia , 2008, Journal of neurochemistry.

[42]  Yung-Hyun Choi,et al.  Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. , 2006, Immunobiology.

[43]  D. Holtzman,et al.  BDNF Protects the Neonatal Brain from Hypoxic-Ischemic InjuryIn Vivo via the ERK Pathway , 2000, The Journal of Neuroscience.

[44]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[45]  J. Roda,et al.  Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke , 2006, Journal of the Neurological Sciences.

[46]  P. Vikman,et al.  Gene expression profiling in the human middle cerebral artery after cerebral ischemia , 2006, European journal of neurology.

[47]  Yong Y. He,et al.  Expression of Immediate Early Gene and Growth Factor mRNAs in a Focal Cerebral Ischemia Model in the Rat , 1993, Stroke.

[48]  P. Young,et al.  Tumor necrosis factor-alpha expression in ischemic neurons. , 1994, Stroke.

[49]  Atsushi Saito,et al.  Neuroprotective Role of a Proline-Rich Akt Substrate in Apoptotic Neuronal Cell Death after Stroke: Relationships with Nerve Growth Factor , 2004, The Journal of Neuroscience.

[50]  P. Gorelick.  Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review , 2002, Stroke.

[51]  P. Amarenco.  Polypill Strategy vs. Prevention Clinics for Stroke Prevention , 2006, Cerebrovascular Diseases.

[52]  M. Chopp,et al.  Gene profiles within the adult subventricular zone niche: proliferation, differentiation and migration of neural progenitor cells in the ischemic brain. , 2007, Current molecular medicine.

[53]  T. Couffinhal,et al.  Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation. , 2008, The American journal of pathology.

[54]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.